Invention Grant
- Patent Title: Methods and products for genetic engineering
-
Application No.: US15769534Application Date: 2016-10-20
-
Publication No.: US10968253B2Publication Date: 2021-04-06
- Inventor: Théophile Ohlmann , Philippe Mangeot , Emiliano Ricci
- Applicant: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) , ECOLE NORMALE SUPERIEURE DE LYON , UNIVERSITE CLAUDE BERNARD LYON 1
- Applicant Address: FR Paris; FR Paris; FR Lyons; FR Villeurbanne
- Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS),ECOLE NORMALE SUPERIEURE DE LYON,UNIVERSITE CLAUDE BERNARD LYON 1
- Current Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS),ECOLE NORMALE SUPERIEURE DE LYON,UNIVERSITE CLAUDE BERNARD LYON 1
- Current Assignee Address: FR Paris; FR Paris; FR Lyons; FR Villeurbanne
- Agency: W&C IP
- Priority: EP15306678 20151020
- International Application: PCT/EP2016/075289 WO 20161020
- International Announcement: WO2017/068077 WO 20170427
- Main IPC: C07K14/005
- IPC: C07K14/005 ; C12N9/22 ; C12N7/00 ; C12N15/10 ; C12N15/113
Abstract:
The present invention relates to a virus-derived particle comprising one or more Cas protein(s), as well as to kits and methods using the same for altering a target nucleic acid.
Public/Granted literature
- US20190055288A1 METHODS AND PRODUCTS FOR GENETIC ENGINEERING Public/Granted day:2019-02-21
Information query
